© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Spectinomycin Hydrochloride Pentahydrate stands as a significant compound in the group of aminocyclitol antibiotics. This material comes from Streptomyces spectabilis, a soil-dwelling bacterium that has given researchers many gifts over the years. The hydrochloride pentahydrate form introduces additional water molecules, binding to the core compound, shaping not only its look and feel but also influencing its handling and storage. Most in the industry know it in solid or powder form, though some labs encounter it as creamy white crystalline flakes and sometimes as pearls, depending on the manufacturing process and level of refinement. Given the nature of this raw material, its molecular and structural traits hold the key to effective and safe usage.
The molecular formula for Spectinomycin Hydrochloride Pentahydrate comes out to C14H24N2O7•2HCl•5H2O. This complex combination brings together the core spectinomycin molecule, two hydrochloric acid segments, and five water molecules—all interconnected. Its chemical structure reveals a unique aminocyclitol core, which underpins its biological activity as a protein synthesis inhibitor. Each segment of water bonded to the molecule matters for storage and solubility, and this influences how it performs across pharmaceutical and research-grade applications. Spectinomycin's core allows it to attach to bacterial ribosomes, which is why it finds heavy use in treating infections, particularly in environments where resistance to other antibiotics poses a problem.
Handling Spectinomycin Hydrochloride Pentahydrate has taught many in labs to respect its stability range and reactivity. In room temperature settings, the compound appears as a white, crystalline solid—sometimes perceived as flakes if prepared through certain crystallization methods. Some suppliers offer this substance in a refined pearl or fine powder consistency, which can make precise measurement easier for pharmaceutical production. Those working with the raw powder will see that it dissolves readily in water, yielding a clear solution—a useful property for injection or oral suspension formulations.
Its density stays near 1.5 g/cm³, with slight variation depending on the specific hydration and packing method used. The powder holds well under dry, cool conditions but can clump when exposed to moisture, reflecting its pentahydrate status. Heating rapidly removes water but risks degrading the pharmaceutical properties. Laboratories commonly use glass containers or polyethylene-sealed bags to maintain purity and avoid cross-contamination.
Hospitals rely on Spectinomycin Hydrochloride Pentahydrate, especially as a last-resort antibiotic for Neisseria gonorrhoeae infections, where resistance to other drugs has become a hurdle. Its mode of action stems from the inhibition of microbial protein synthesis, targeting bacterial ribosomes. The crystalline solid dissolves well in water, allowing hospital pharmacies to prepare both oral solutions and injectables. This material does not have widespread industrial or agricultural applications, and its main role remains clinical.
On a molecular level, Spectinomycin shows minimal cross-reactivity with human cellular machinery, a quality that helps lower toxicity during treatment. Some may view the five water molecules of hydration as trivial, but based on experience in stability studies, those water molecules prevent rapid degradation—a key concern when shelf life and dosage reliability mean the difference between effective therapy and waste.
Customs authorities track Spectinomycin Hydrochloride Pentahydrate shipments under the HS Code 2941.90, part of the broader classification for antibiotics, especially those not listed elsewhere. Knowing this code proves vital both for importers securing raw materials for compounding and for clinics involved in large-scale acquisition. Regulatory bodies in many countries demand strict adherence to pharmaceutical GMP (Good Manufacturing Practice) standards, which pushes suppliers to maintain rigorous purity metrics, precise molecular composition, and consistent density.
Typical batches pass through multi-stage purity evaluation, measured by liquid chromatography and mass spectrometry, checking for any loss of hydration, crystallinity, or contamination. Only qualified batches move forward for treatment use. Hospitals and compounding facilities keep detailed records, referencing both the HS Code and the lot-level molecular data, as part of pharmaceutical traceability protocols.
In working directly with Spectinomycin Hydrochloride Pentahydrate, safety stands as a constant theme. The solid, powder, flakes, or pearl form demands dust-minimizing techniques during mixing or weighing. Good laboratory practice calls for gloves, masks, and sometimes goggles since even pharmaceutical-grade powders carry inhalation and contact risks if handled carelessly. Mixing this compound in solution highlights its high water solubility but calls for close monitoring of pH and sterility.
The compound is not classified as a severe environmental hazard under normal usage, but poor disposal of the raw material or large-scale dumping can lead to contamination of water supplies, contributing to the spread of antibiotic resistance. Clinical settings rely on established hazardous waste disposal protocols, preventing such outcomes. Exposure risks center mainly on hypersensitivity reactions, which underline the need for caution in patients with a history of allergic response to aminocyclitol antibiotics.
The reality for many in the pharmaceutical and clinical settings is that access to stable, high-purity Spectinomycin Hydrochloride Pentahydrate sets the tone for treatment success. Many countries struggle with supply chain bottlenecks or regulatory roadblocks, and inadequate storage or impure material leads to wasted resources and, worst case, ineffective treatment. Ongoing training for material handling, pressure on manufacturers to provide full molecular and impurity profiles, and broader collaboration across customs, regulatory, and pharmaceutical networks stand out as areas needing investment.
Improvements often begin on the ground: better sealed storage, increased monitoring of density and hydration by batch, and more open sharing of analytical data between suppliers and end-users. Resilient supply lines built on transparency and science-based evaluation keep clinics stocked with safe, effective compounds and help public health officials respond quickly during outbreaks. As someone who has watched the difference these approaches make, investing in robust traceability and education pays back, giving both patients and practitioners new confidence in this indispensable chemical raw material.
